Watts Releases its 2024 Sustainability Report
Article content
NORTH ANDOVER, Mass. — Watts Water Technologies, Inc. (NYSE: WTS) – through its subsidiaries, one of the world's leading manufacturers and providers of plumbing, heating, and water quality products and solutions – today announced the release of its 2024 Sustainability Report, which highlights the Company's environmental, social and governance practices and its commitment to best-in-class sustainability performance.
Article content
'Throughout 2024, we celebrated our 150th anniversary by reaffirming our sustainability commitment for the future: to improve the comfort, safety, and quality of life for people around the world through our expertise in a wide range of water technologies.'
Article content
'Throughout 2024, we celebrated our 150 th anniversary by reaffirming our commitment for the future: to improve the comfort, safety, and quality of life for people around the world through our expertise in a wide range of water technologies,' said Robert J. Pagano, Jr., CEO, President, and Chairperson of the Board. 'We also made substantial progress with respect to our environmental, social, and governance (ESG) strategy, including continued reductions to our environmental footprint; creating positive impact through community outreach; and bringing unprecedented insights and value to our customers, shareholders, and the environment with our latest smart and connected digital solutions. As we look toward the future, we are excited to continue our work to advance our vision for a world where water is safeguarded for all.'
Article content
Key Watts accomplishments highlighted in the report include:
Article content
Initiated work toward our second generation of Footprint goals, including tracking our GHG emissions performance against an absolute reduction target of 30%, which is equivalent to 10,000 metric tons (MT), by 2034.
Reduced 950 MT of CO2, a result of new investments in renewable energy, system upgrades and equipment efficiencies, and broadening awareness of energy reduction targets across Watts sites.
Reduced our hazardous waste intensity by 16%, a result of investments and process innovations at Watts sites that are the highest producers of hazardous waste.
Built on a decade of data collection and water reduction initiatives across sites, we achieved a 62% reduction in water intensity between 2018 and 2023. In 2024, we began tracking our water intensity against our consolidated baseline, reducing over 600,000 liters of water. Meeting our aggressive water reduction target will require even more innovation and capital investments.
Completed Life Cycle Assessments (LCAs) for 100% of products in our largest facility in Franklin, NH, USA, which means more than 7,500 Watts products are now covered by LCAs. We also initiated LCAs for all products in our BLÜCHER facility to be completed by the end of 2025.
Introduced Nexa, an intelligent water management solution for commercial buildings that supports customers in the safe, efficient, and sustainable delivery of water while achieving significant cost savings.
Launched the Watts Cares volunteer program, a resounding success with colleagues from more than 40 sites giving more than 5,000 hours of their time, expertise, and passion to more than 50 different organizations within their communities and beyond
Provided clean water access to vulnerable communities through our ongoing partnership with Planet Water Foundation, which to date has benefited nearly 92,000 people in nine different countries.
Recognized as one of America's Greenest Companies by Newsweek, selected as one of America's Climate Leaders since 2023 by USA Today and earned Newsweek's designation as one of America's Most Responsible Companies for the sixth consecutive year, ranking among the Top 600 from 2,000 major U.S. firms across 14 industries. Also selected as one of the World's Greenest Companies 2025 by Newsweek and America's Top GreenTech Companies 2025 by TIME.
Named one of Top Places to Work Massachusetts since 2023 (North Andover Headquarters) by The Boston Globe – a result of the incorporation of employee engagement and inclusivity efforts as one of our strategic pillars, cultural behaviors, and global performance management, which is helping to build a high-performance, values-driven culture that welcomes and celebrates every team member.
Article content
Article content
Article content
Article content
Contacts
Article content
Watts Water Technologies, Inc.
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
31 minutes ago
- CTV News
Teck Resources eyes output boost for chipmaking-metal germanium
The Teck Resources logo is seen on a podium before the company's special meeting of shareholders, in Vancouver, B.C., Wednesday, April 26, 2023. THE CANADIAN PRESS/Darryl Dyck LONDON — Canada's Teck Resources is weighing options to expand production of germanium, a strategic metal key to chipmaking, and is currently talking with governments, including Canada and the United States, on available funding, said Doug Brown, VP communications & government affairs. Teck's plan comes amid growing efforts to diversify supplies of critical minerals needed for the tech and defense sectors, as geopolitical tensions and trade barriers complicate access to materials mainly produced or refined in China. 'We are examining options and market support for increasing production capacity of germanium,' he told Reuters. China, which supplies around 60 per cent of the world's refined germanium, restricted exports of the metal - along with gallium and antimony, all having broad military applications - to the United States, further escalating trade tensions between the world's two largest economies following Washington's crackdown on Beijing's chip sector. The export curbs were part of a broader effort launched in 2023, when China began imposing restrictions on critical mineral shipments, citing national security concerns. By controlling the export of these minerals, China aims to exert influence over the industries that use them, including renewable energy, defense, and chip manufacturing. Germanium is also used in semiconductors and infrared technology, fiber optic cables and solar cells. Teck is exploring ways to add to the current processing line using existing technology as one of the options, Brown said. Teck is North America's biggest germanium producer, and the fourth largest globally. Most of its germanium, a by-product of zinc ore concentrate at its Red Dog operations in Alaska, goes to the United States, via smelting and refining in British Columbia. Canada's germanium exports to the United States are currently exempt from tariffs as they comply with the USMCA (United States, Mexico, Canada) trade agreement. In a speech in Washington last January, Canada's Energy and Natural Resources Minister Jonathan Wilkinson welcomed partnerships with the United States to invest in critical minerals, including germanium. Canada's Energy Ministry declined to comment on funding for Teck, while saying that the prime minister is leading broader trade negotiations with the United States. (Reporting by Clara Denina; editing by David Evans)
Globe and Mail
an hour ago
- Globe and Mail
Why GMS Stock Is Soaring Today
A bidding war appears to be brewing for building products distribution company GMS (NYSE: GMS), and investors are excited by the possibilities. Shares of GMS jumped 26% on Friday morning after the company was put in play by an unsolicited suitor. A building products bidding war? GMS is a construction products distributor and tool supplier for consumer and commercial customers. Late Wednesday, QXO (NYSE: QXO) proposed acquiring the business for about $5 billion, or $95.20 per share in cash, a premium of 27% to GMS's 60-day volume-weighted average. QXO is a roll-up put together by Brad Jacobs, the M&A specialist behind companies including XPO and United Rentals. The company did its first deal in April, acquiring Beacon Roofing Supply for $11 billion, and continues to seek out acquisition opportunities toward its goal to build a $50 billion business in the years to come. GMS said its board would review the proposal. QXO set a deadline of June 24 for a response, saying it intends to go directly to GMS shareholders if a deal can't be worked out. But QXO might have competition for the business. Late Thursday, The Wall Street Journal reported that Home Depot (NYSE: HD) has also made an offer for GMS. So far, Home Depot has not gone public with a bid, and it is unclear what price it is offering for GMS. Is GMS stock a buy? Though nothing is certain, with two deep-pocketed suitors, it appears likely that GMS's time as an independent company is nearing an end. And it is possible that, since there are two bidders, the sale will be for a higher price than the $95.20-per-share QXO offer. The market is already pricing that in, bidding GMS shares as high as $104 on Friday morning. Though both Home Depot and QXO have the resources to engage in a bidding war, both have smart management teams and solid strategies and seem unlikely to dramatically overpay. It is also unclear whether Home Depot was simply being opportunistic, or if the company considers GMS to be strategic enough to engage in a battle. Given the uncertainty of the outcome and the considerable premium already priced into GMS shares, investors should tread carefully. Should you invest $1,000 in Gms right now? Before you buy stock in Gms, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Gms wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $659,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $891,722!* Now, it's worth noting Stock Advisor 's total average return is995% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025
Globe and Mail
an hour ago
- Globe and Mail
Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market
PITTSBURGH, June 20, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (OTC: LIPO) ('Lipella' or the 'Company'), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet needs, today announced that the Nasdaq Hearings Panel has determined to delist the Company's common stock from The Nasdaq Capital Market. Trading in the common stock was suspended at the open of business today. The delisting follows Nasdaq's determination that certain private placement transactions completed between December 2024 and March 2025 did not comply with Listing Rules 5100 (Public Interest Concern), 5635 (Shareholder Approval), and 5640 (Voting Rights). Specifically, Nasdaq cited the issuance of Series C voting convertible preferred stock and warrants to the Company's placement agent and advisor to those transactions, as having been structured in a way that triggered these rule violations. The Company was notified by the Hearings Panel of its determination to delist the Company's common stock effective today. Lipella is disappointed by this decision—particularly in light of the fact that it was taking immediate steps to obtain stockholder approval and address the concerns raised by Nasdaq. Lipella remains operationally sound, and its business fundamentals are intact. The Company is executing on its strategic and clinical development plans, including continued advancement of its lead product candidates LP-10 for hemorrhagic cystitis and LP-310 for oral lichen planus. In parallel, Lipella is actively exploring other markets to list its common stock and is committed to relisting its shares on a trading venue that provides the best possible liquidity and access for investors. The Company's common stock is currently quoted on the OTC Markets under the symbol 'LIPO.' 'We acknowledge Nasdaq's decision and are focused on taking swift, constructive steps accordingly,' said Dr. Jonathan Kaufman, Chief Executive Officer of Lipella. 'Our commitment to our shareholders, our mission, and our clinical goals has not changed.' The Company remains a reporting company under the Securities Exchange Act of 1934 and will continue to file periodic reports and disclosures with the U.S. Securities and Exchange Commission. Lipella will keep its stockholders informed of all material developments as it continues to assess its options. About Lipella Pharmaceuticals Inc. Lipella Pharmaceuticals is a clinical-stage biotechnology company focused on developing new drugs by reformulating active agents in existing generic drugs and optimizing these reformulations for new applications. Lipella targets diseases with significant unmet needs, where no approved drug therapies currently exist. The company completed its initial public offering in 2022. Learn more at and follow us on X and LinkedIn. Forward-Looking Statements This press release includes certain "forward-looking statements." All statements, other than statements of historical fact, included in this press release regarding, among other things, our strategy, including with respect to the Company's exploration of all markets and its commitment to list its common stock, future operations, financial position, prospects, clinical trials, regulatory approvals, pipeline and opportunities, sources of growth, successful implementation of our proprietary technology, plans and objectives are forward-looking statements. Forward-looking statements can be identified by words such as "may," "will," "could," "continue," "would," "should," "potential," "target," "goal," "anticipates," "intends," "plans," "seeks," "believes," "estimates," "predicts," "expects," "projects" and similar references to future periods. Forward-looking statements are based on our current expectations and assumptions regarding future events and financial trends that we believe may affect among other things, market and other conditions, our financial condition, results of operations, business strategy, short- and long-term business operations and objectives, and financial needs. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you, therefore, against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. There are risks, uncertainties and other factors, both known and unknown, that could cause actual results to differ materially from those in the forward-looking statements which include, but are not limited to, general capital market risks, regional, national or global political, economic, business, competitive, market and regulatory conditions, and other risks that may be included in the periodic reports and other filings that the Company files from time to time with the U.S. Securities and Exchange Commission. Any forward-looking statement made by us is based upon the reasonable judgment of our management at the time such statement is made and speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law. Nothing contained herein is, or shall be relied upon as, a promise or representation as to the past or future. In addition, the information contained in this press release is as of the date hereof, and the Company has no obligation to update such information, including in the event that such information becomes inaccurate. You should not construe the contents of this press release as legal, tax and financial advisors as to legal and related matters concerning the matters described herein. CONTACT: Jonathan Kaufman Chief Executive Officer Lipella Pharmaceuticals Inc. Info@ 1-412-894-1853 PCG Advisory Jeff Ramson jramson@
